These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33240132)

  • 1. Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis.
    Kocsis A; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Grent-'t-Jong T; Uhlhaas PJ
    Front Psychiatry; 2020; 11():580503. PubMed ID: 33240132
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Haining K; Matrunola C; Mitchell L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Psychol Med; 2020 Jan; 50(1):77-85. PubMed ID: 30862319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of resting-state heart rate variability in psychosis: A comparison with clinical high risk, anxiety, and healthy controls.
    Clamor A; Sundag J; Lincoln TM
    Schizophr Res; 2019 Apr; 206():89-95. PubMed ID: 30573408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis.
    McDonald M; Christoforidou E; Van Rijsbergen N; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Schizophr Bull; 2019 Apr; 45(3):600-609. PubMed ID: 29889271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey-matter abnormalities in clinical high-risk participants for psychosis.
    Zikidi K; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Fracasso A; Uhlhaas PJ
    Schizophr Res; 2020 Dec; 226():120-128. PubMed ID: 31740178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of suicidality and non-suicidal self-harm among individuals at clinical high-risk for psychosis: Results from a community-recruited sample.
    Haining K; Karagiorgou O; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Early Interv Psychiatry; 2021 Oct; 15(5):1256-1265. PubMed ID: 33372364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.
    Schultze-Lutter F; Walger P; Franscini M; Traber-Walker N; Osman N; Walger H; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2022 Mar; 12(3):425-449. PubMed ID: 35433326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
    Staines L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    BMC Psychiatry; 2021 Jul; 21(1):339. PubMed ID: 34233651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying functional network changing patterns in individuals at clinical high-risk for psychosis and patients with early illness schizophrenia: A group ICA study.
    Du Y; Fryer SL; Lin D; Sui J; Yu Q; Chen J; Stuart B; Loewy RL; Calhoun VD; Mathalon DH
    Neuroimage Clin; 2018; 17():335-346. PubMed ID: 29159045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosis.
    Schwarzer JM; Meyhoefer I; Antonucci LA; Kambeitz-Ilankovic L; Surmann M; Bienek O; Romer G; Dannlowski U; Hahn T; Korda A; Dwyer DB; Ruef A; Haas SS; Rosen M; Lichtenstein T; Ruhrmann S; Kambeitz J; Salokangas RKR; Pantelis C; Schultze-Lutter F; Meisenzahl E; Brambilla P; Bertolino A; Borgwardt S; Upthegrove R; Koutsouleris N; Lencer R;
    Neuropsychopharmacology; 2022 Nov; 47(12):2051-2060. PubMed ID: 35982238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.
    Modinos G; Allen P; Zugman A; Dima D; Azis M; Samson C; Bonoldi I; Quinn B; Gifford GWG; Smart SE; Antoniades M; Bossong MG; Broome MR; Perez J; Howes OD; Stone JM; Grace AA; McGuire P
    Schizophr Bull; 2020 Apr; 46(3):670-679. PubMed ID: 32227226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.
    Kindler J; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Walther S; Schimmelmann BG; Hubl D
    Schizophr Bull; 2018 Jan; 44(1):182-192. PubMed ID: 28575528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long range temporal correlations (LRTCs) in MEG-data during emerging psychosis: Relationship to symptoms, medication-status and clinical trajectory.
    Cruz G; Grent-'t-Jong T; Krishnadas R; Palva JM; Palva S; Uhlhaas PJ
    Neuroimage Clin; 2021; 31():102722. PubMed ID: 34130193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.